272 results on '"Carlsson, Thomas"'
Search Results
2. Desipramine, commonly used as a noradrenergic neuroprotectant in 6-OHDA-lesions, leads to local functional changes in the urinary bladder and gastrointestinal tract in healthy rats
3. Cross-organ sensitization between the prostate and bladder in an experimental rat model of lipopolysaccharide (LPS)-induced chronic pelvic pain syndrome
4. Student Characteristics Associated with Passing the Exam in Undergraduate Pharmacology Courses—a Cross-sectional Study in Six University Degree Programs
5. 6-OHDA-Induced Changes in Colonic Segment Contractility in the Rat Model of Parkinson’s Disease
6. Animal Models of Parkinson’s Disease
7. Evidence based residential ventilation: sizing procedure and system solutions addressed by REHVA Residential Ventilation Task Force
8. Treatment with the soluble guanylate cyclase activator BAY 60–2770 normalizes bladder function in an in vivo rat model of chronic prostatitis
9. Increased excitability in serotonin neurons in the dorsal raphe nucleus in the 6-OHDA mouse model of Parkinson's disease
10. Autonomic Receptor‐mediated Regulation of Production and Release of Nitric Oxide in Normal and Malignant Human Urothelial Cells
11. Extent of pre-operative L-DOPA-induced dyskinesia predicts the severity of graft-induced dyskinesia after fetal dopamine cell transplantation
12. A Randomized, Controlled Trial of Fusion Surgery for Lumbar Spinal Stenosis
13. Novel Insights Into Muscarinic and Purinergic Responses in Primary Cultures of Rat Lacrimal Gland Myoepithelial Cells
14. KEEP MOVING: COMMUNICATION AND SAFETY CHALLENGES FACING MOBILE ROBOT MANUFACTURERS.
15. Serotonin neuron-dependent and -independent reduction of dyskinesia by 5-HT 1A and 5-HT 1B receptor agonists in the rat Parkinson model
16. Memory deficits correlate with tau and spine pathology in P301S MAPT transgenic mice
17. Involvement of the serotonin system in l-dopa-induced dyskinesias
18. Selegiline normalizes, while l-DOPA sustains the increased number of dopamine neurons in the olfactory bulb in a 6-OHDA mouse model of Parkinsonʼs disease
19. Prostate‐to‐bladder cross‐sensitization in a model of zymosan‐induced chronic pelvic pain syndrome in rats
20. Total Hip Replacement Versus Open Reduction and Internal Fixation of Displaced Femoral Neck Fractures: A Randomized Long-Term Follow-up Study
21. Moisture sensor at glass/polymer interface for monitoring of photovoltaic module encapsulants
22. Absorption and desorption of water in glass/ethylene-vinyl-acetate/glass laminates
23. Graft placement and uneven pattern of reinnervation in the striatum is important for development of graft-induced dyskinesia
24. Biodistribution and brain permeability of the extracellular domain of neuregulin-1-β1
25. Systemic administration of neuregulin-1β1 protects dopaminergic neurons in a mouse model of Parkinsonʼs disease
26. Functional atropine sensitive purinergic responses in the healthy rat bladder
27. In vivo paracrine effects of ATP-induced urothelial acetylcholine in the rat urinary bladder
28. Combination drug therapy against OAB normalizes micturition parameters and increases the release of nitric oxide during chemically induced cystitis
29. Optimized adeno-associated viral vector-mediated striatal DOPA delivery restores sensorimotor function and prevents dyskinesias in a model of advanced Parkinson’s disease
30. Role of serotonin neurons in the induction of levodopa- and graft-induced dyskinesias in Parkinsonʼs disease
31. Optimization of continuous in vivo DOPA production and studies on ectopic DA synthesis using rAAV5 vectors in Parkinsonian rats
32. Serotonin neuron-dependent and -independent reduction of dyskinesia by 5-HT1A and 5-HT1B receptor agonists in the rat Parkinson model
33. Impact of grafted serotonin and dopamine neurons on development of L-DOPA-induced dyskinesias in parkinsonian rats is determined by the extent of dopamine neuron degeneration
34. Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia
35. Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats
36. Reversal of dyskinesias in an animal model of Parkinsonʼs disease by continuous L-DOPA delivery using rAAV vectors
37. Dissociation between short-term increased graft survival and long-term functional improvements in Parkinsonian rats overexpressing glial cell line-derived neurotrophic factor
38. Whole Blood Measurements with Thermal Micro-Biosensors
39. Acoustic white noise ameliorates reduced regional brain expression of CaMKII and ΔFosB in the spontaneously hypertensive rat model of ADHD
40. Effects of caveolae depletion and urothelial denudation on purinergic and cholinergic signaling in healthy and cyclophosphamide-induced cystitis in the rat bladder
41. Urothelial acetylcholine involvement in ATP-induced contractile responses of the rat urinary bladder
42. Piericidin A Aggravates Tau Pathology in P301S Transgenic Mice
43. l-DOPA-induced dyskinesia is associated with a deficient numerical downregulation of striatal tyrosine hydroxylase mRNA-expressing neurons
44. Svävare: Konstruktion av hytt till en svävare
45. Predictive value of severity of preoperative L-DOPA induced dyskinesia for the development of graft-induced dyskinesia in the rat Parkinson model
46. Local Change in Urinary Bladder Contractility Following CNS Dopamine Denervation in the 6-OHDA Rat Model of Parkinson’s Disease
47. Piericidin A Aggravates Tau Pathology in P301S Transgenic Mice
48. Homework for English from the Students’ Perspective
49. Animal Models of Parkinson’s Disease
50. Tau Silencing by siRNA in the P301S Mouse Model of Tauopathy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.